Autopsy report · NCT00369070
A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC
Cause of deathNo reason given
Life of this trial
- Registered 5 months before it started.
- Ran for about 4 years 6 months before it stopped.
- 186 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Amgen
- Sponsor type
- Industry
- Conditions
- Advanced Non-squamous NSCLC
- Interventions
- Bevacizumab; AMG 706; Paclitaxel; Carboplatin
- Participants
- 186
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.